MDEL Phase II: The New Online Form and the 1 December 2026 Date

On 30 October 2026, Health Canada's Medical Devices Compliance Program issued a short bulletin that changes two practical things for every medical device importer and distributor in Canada. First, the Phase 2 amendments to the Medical Devices Regulations now come into force on 1 December 2026, not 14 December 2026. Second, the Medical Device Establishment Licence (MDEL) application form, FRM-0292, moves to an online only submission process. If your team was planning around the December 14 date that still appears on some Health Canada landing pages, your window just shortened.

This is not a minor administrative tweak. The MDEL is the licence that lets you import or distribute medical devices in Canada, and the amendments registered as SOR/2026-110 expand what you must tell Health Canada about your manufacturers and suppliers and how you document your procedures. The guide to the new form, GUI-0016, has been revised to match. Below is what changed, what the regulation still requires, and a practical plan to be ready on the new form before the 1 December deadline.

Executive summary

The 30 October 2026 bulletin corrects the coming into force date to 1 December 2026 and makes the MDEL application online only. The amended Medical Devices Regulations (SOR/2026-110) were registered in the Canada Gazette, Part II on 4 June 2026, and come into force 180 days later, which is 1 December 2026. From that date, stakeholders must use the revised FRM-0292, which is completed and submitted solely online rather than by email.

What to do now: confirm which of your activities need an MDEL, map your manufacturers and suppliers to the reordered form sections, update the people and procedures that support your licence, and file any new application or amendment on the online form from 1 December. Treat the next few weeks as the runway, not the deadline.

What changed on 30 October 2026

Health Canada corrected the in force date and confirmed the move to an online form. In its MDEL bulletin of 30 October 2026, the Medical Devices Compliance Program states that the amended regulations come into force on 1 December 2026, 180 days after being registered in the Canada Gazette, Part II on 4 June 2026, and that this is a correction to the date mentioned in the earlier 17 June 2026 bulletin. The bulletin also describes the key changes to the form and guide.

Why it matters. Some Health Canada form and guidance landing pages were still titled around a 14 December 2026 effective date when the bulletin was issued. When an official correction and the pages that reference the form disagree, the correction in the compliance bulletin is the statement to plan against. The practical effect is that your obligation to use the new online form begins two weeks earlier than the figure many teams had written into their plans.

What to do. Replace every internal reference to 14 December with 1 December 2026. Tell whoever owns your regulatory calendar, and check our Q4 2026 regulatory deadline calendar for Canada so the corrected date sits alongside your other year end obligations.

The date correction at a glance

The new online FRM-0292 form: what is different

The MDEL application is no longer submitted by email, and the form itself has been reorganized. Health Canada's stated intent is to replace the existing Portable Document Format (PDF) form with an online submission process that streamlines the user experience. Three changes matter most in day to day terms.

1. Online only submission. The form can be accessed, completed and submitted solely online using the links Health Canada provides. The email route goes away. Until the regulations come into force on 1 December 2026, the existing PDF form should continue to be used, so there is a clean switch over point rather than a transition period.

2. Sections 4 and 5 reordered. Section 4 now refers to manufacturers and suppliers, and section 5 refers to sites. If you reuse old working documents or internal templates to assemble an application, the section numbering will not line up with the new form.

3. Acknowledgement replaces the signature. The senior official's signature is replaced with an Acknowledgement, completed by entering the individual's position or title, name and date. Build that into your internal sign off so the right person still reviews the application before it is submitted.

What the Phase 2 amendments require

SOR/2026-110 modernizes the establishment licensing framework under the Medical Devices Regulations (SOR/98-282). The amendments were registered on 4 June 2026 and expand the establishment information MDEL applicants and holders provide, including the manufacturers and suppliers behind the devices they import or distribute, which is why the form now dedicates a section to that information. They also reinforce the expectation that licence holders maintain documented procedures for the activities that protect device quality, such as distribution records, complaint handling and recalls.

Read the regulation for the specifics that apply to you. Scope and wording vary by activity (import, distribute, or both) and by device class. Confirm the exact requirements in SOR/2026-110 in the Canada Gazette, Part II and in the revised Guidance on medical device establishment licensing (GUI-0016), rather than relying on a summary.

Keep your recall and reporting duties in view. An MDEL does not stand alone. If you import or distribute, you still carry recall and reporting obligations under the Medical Devices Regulations. Our guide to medical device recall reporting in Canada under SOR/98-282 explains how those duties connect to your establishment licence, and licence holders who also manage Class III and IV products should review the expectations for Class III and IV medical device licence applications.

Who must act, and what to do before 1 December

Any business that imports or distributes medical devices in Canada and needs an MDEL is affected. That includes importers, distributors, and manufacturers of Class I devices who sell them in Canada. Here is a practical sequence to be ready on the online form.

Step 1: Confirm your licence need and timing. Decide whether you are filing a new application, an amendment, or your annual licence review on or after 1 December 2026. Anything submitted from that date uses the online form.

Step 2: Assemble manufacturer and supplier information. Build a current list of the manufacturers and suppliers behind every device you handle, because section 4 of the new form asks for it. A supplier qualification approach helps here; see our note on supplier qualification and risk tiering.

Step 3: Update your documented procedures. Review your distribution records, complaint handling and recall procedures so they reflect current practice and the amended regulations. If you are unsure how ready you are, a short GMP and inspection readiness self assessment is a fast way to find gaps.

Step 4: Set your online sign off. Decide who will complete the Acknowledgement (position or title, name and date) and make sure that person reviews the application first. Companion guidance in our article on Canada's new MDEL rules in force December 2026 walks through the broader framework.

A practical example

Consider a mid sized importer that distributes Class I and Class II devices and had pencilled 14 December into its plan. The team intended to file an amendment in early December to add a new supplier, using the familiar emailed PDF. Under the corrected timeline, an amendment submitted on 2 December 2026 falls after the 1 December in force date, so it must go on the online form with the new section 4 supplier fields and an Acknowledgement rather than a signature. A team that only discovers this at submission loses days reformatting information and chasing the right sign off. A team that prepared the supplier list and named its Acknowledgement owner in advance simply enters the data and submits.

How the MDEL connects to your wider device obligations

The establishment licence is one piece of a connected compliance picture. Importers and distributors also manage licence renewals, recalls, and device traceability. If your annual licence review is due, our guide to the medical device licence renewal deadline in Canada explains the timing. If you handle recalls, strong serial number and UDI traceability makes them faster and cleaner. And if you also sell into the European Union, the EUDAMED pre flight checklist for MDEL holders shows how your Canadian and EU obligations line up. Keeping these systems aligned is what turns a form change into a non event.

MDEL Phase II readiness checklist

• Date corrected: every plan and calendar now reads 1 December 2026, not 14 December.
• Scope confirmed: you know whether you import, distribute, or both, and which device classes you handle.
• Manufacturers and suppliers: a current, complete list is ready for section 4 of the online form.
• Sites: all sites are documented for section 5.
• Documented procedures: distribution records, complaint handling and recall procedures are current and match the amended regulations.
• Acknowledgement owner: the right senior person is named to complete the Acknowledgement (position or title, name, date).
• Online access: your team can reach and complete the online FRM-0292 through Health Canada's links.
• Recall and reporting: your mandatory problem reporting and recall duties are mapped to your licence.

Common mistakes to avoid

• Planning to the wrong date. Using 14 December when the corrected in force date is 1 December 2026 costs you two weeks of runway.
• Assuming email still works. From 1 December, the application is online only. A last minute emailed PDF will not be the current route.
• Reusing old section numbering. Sections 4 and 5 are reordered, so copy and paste from old files can misplace information.
• Treating the Acknowledgement as a formality. It still represents senior sign off. Skipping real review is a governance gap an inspector can see.
• Incomplete supplier information. A thin manufacturer and supplier list slows review and signals weak oversight.
• Forgetting post licence duties. The MDEL is the start. Recall, reporting and record keeping obligations continue after the licence is granted.

Frequently asked questions

When do the MDEL Phase 2 amendments come into force?

The amended Medical Devices Regulations come into force on 1 December 2026, which is 180 days after registration in the Canada Gazette, Part II on 4 June 2026. The 30 October 2026 bulletin corrected an earlier reference to 14 December 2026.

Is the MDEL application still submitted by email?

No. From 1 December 2026, the revised FRM-0292 is completed and submitted solely online through the links Health Canada provides. Until that date, the existing PDF form should continue to be used.

What is SOR/2026-110?

SOR/2026-110 is the Regulations Amending the Medical Devices Regulations (Establishment Licences), registered on 4 June 2026. It modernizes the MDEL framework, including the information applicants provide about manufacturers and suppliers.

What changed on the form itself?

Sections 4 and 5 were reordered, so section 4 now covers manufacturers and suppliers and section 5 covers sites, and the senior official's signature is replaced with an Acknowledgement completed by entering a position or title, name and date.

Do I need to reapply if I already hold an MDEL?

You do not lose your licence because the form changed. The new online form applies to applications, amendments and your annual licence review submitted on or after 1 December 2026. Confirm your next submission type and timing, and prepare the new information fields in advance.

Which Health Canada documents should I rely on?

Rely on the 30 October 2026 MDEL bulletin, the revised FRM-0292 instructions, the revised GUI-0016 guidance, and SOR/2026-110 in the Canada Gazette, Part II. Where a summary and an official document disagree, follow the official document.

How MFLRC can help

MFLRC helps importers, distributors and manufacturers file MDEL applications correctly and on time. We map your activities to the right licence, build the manufacturer and supplier information the new section 4 expects, and review your documented procedures against the amended regulations. Our regulatory affairs and quality assurance teams support new MDEL applications and amendments, gap assessments, SOP development, QMS and ISO 13485 alignment, import and export compliance, and inspection readiness, so your licence reflects how you actually operate.

If you need your MDEL application prepared and filed correctly on the new online form before 1 December 2026, we can help you plan the work backward from the date and close any gaps first.

Conclusion

The 30 October 2026 bulletin did two things that change your plan: it corrected the MDEL Phase 2 in force date to 1 December 2026 and confirmed the move to an online only FRM-0292. The substance of SOR/2026-110, more complete manufacturer and supplier information and documented procedures, rewards companies that treat the next few weeks as preparation time. Fix the date in your calendar, assemble the information the new form asks for, and decide who signs off, and the switch on 1 December becomes routine rather than a scramble.

Sources and references

• Health Canada, MDEL bulletin: updates to the application form (FRM-0292) and guidance (GUI-0016), 30 October 2026
• Canada Gazette, Part II: Regulations Amending the Medical Devices Regulations (Establishment Licences), SOR/2026-110
• Health Canada, Phase 2 of our work to modernize medical device establishment licensing
• Health Canada, Guidance on medical device establishment licensing (GUI-0016)
• Medical Devices Regulations (SOR/98-282)